When tissues are injured and blood vessels clotted, the local environment becomes ischemic -lack of adequate supply of oxygen and glucose delivered to the surrounding cells. The heat shock protein-90 (Hsp90) family proteins protect tissues from various environmental insults and participate in the damaged tissue repair. Here we report discovery of a novel ischemia-responsive mechanism by which the two Hsp90 isoforms, Hsp90α and Hsp90β, work together to promote cell motility in wounded skin and accelerate wound closure. We demonstrate that Hsp90α and Hsp90β have distinct and non-exchangeable functions during wound healing. Under hypoxia and lack of serum factors, Hsp90 binds to the cytoplasmic tail of the LDL Receptor-Related Protein-1 (LRP-1) and stabilizes the receptor at the cell surface. Hsp90α, however, is secreted by the cell into extracellular space, where it binds and signals through the LRP-1 receptor to promote cell motility, leading to wound closure. In addition to skin injury, we suggest that this repair mechanism applies broadly to other non-cutaneous injured tissues.
Introduction
The microenvironment of wounded tissues is hypoxic and lack continued nutrient supply due to vascular disruption and high oxygen consumption by cells at the wound edge (Pai et al., 1992) .
Acute hypoxia in injured tissues is also a critical environmental cue that triggers initiation of the wound healing processes (Tandara et al., 2004) . For instance, it has been shown that hypoxia promotes migration of human keratinocytes, the cell responsible for wound closure via reepithelialization (O'Tool et al., 1997) , and migration of human dermal fibroblasts, which deposit new extracellular matrices to the wound and support subsequent wound remodeling (Mogford et al., 2002) . On the other hand, impaired responses to hypoxia are associated with impaired wound healing, such as the environment in chronic diabetic wounds (Botusan et al., 2008) . In diabetic foot ulcers, in particular, the stability of the hypoxia-inducible factor-1alpha (HIF-1α) protein is compromised due to the hyperglycemic environment, albeit the mechanism remains unclear (Catrina et al., 2004; Fadini et al., 2006; Gao et al., 2005) . These in vitro and in vivo studies suggest that acute hypoxia is a natural shock signal to the injured tissues and, more importantly, a call for an immediate jump-start of wound healing. However, how the cells in the injured tissue cope with the new environment of hypoxia and then respond to it remained little beyond speculations. In this study, we show that the two heat shock protein-90 family members, Hsp90α and Hsp90β, work together in a unique fashion to repair skin wounds. Hsp90β works inside the cell to stabilize the LRP-1 receptor at the cell surface. Hsp90α, however, is being secreted to the extracellular space to bind and transmit pro-motility signal via the stabilized LRP-1 receptor.
Together, these two Hsp90 isoforms promote the early phase of wound healing, i.e. wound closure, under hypoxia and nutrient paucity.
Results and Discussion
Hsp90α, but not Hsp90β, acts extracellularly to mediate hypoxia-triggered dermal fibroblast migration.
To establish the individual role of Hsp90α and Hsp90β in hypoxia-driven human dermal fibroblast (HDF) migration, a critical event during wound healing, we wanted to selectively down-regulate Hsp90α or Hsp90β in the cells. In order to prove isoform-specific downregulation, we first verified the specificity of anti-Hsp90α and anti-Hsp90β antibodies. As shown in Figure 1A We next compared motility of these Hsp90α-or Hsp90β-knockdown cells in response either to PDGF-BB (the major growth factor for HDFs) stimulation (a physiological condition) or to an acute hypoxia (stress) using the colloidal gold migration assay (Li et al., 2004) . In the absence of any stimuli and serum-free conditions, all cells showed a basal motility ( Figure 1C (Li et al., 2007 ). Thus, we tested if extracellular supplementation with Hsp90 or Hsp90 protein rescues the motility defect in Hsp90α-or Hsp90β-downregulated HDFs in response to hypoxia. We found that only the addition of recombinant Hsp90, but not Hsp90, protein was able to rescue the motility of Hsp90α-downregulated HDFs (panel j vs. panel l). However, neither Hsp90 nor Hsp90 was able to rescue the motility defect of Hsp90β-downregulated HDFs (panels k and m). Computer-assisted quantitation of the migration data was shown in Figure 1D . The above results indicated that 1) Hsp90α, but not Hsp90, acts outside the cells to mediate hypoxia-induced HDF motility; 2) the extracellular role for Hsp90α could not be replaced by Hsp90, and 3) the extracellular Hsp90α action requires the presence of intracellular Hsp90β.
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To verify the finding that secreted Hsp90α mediates hypoxia-stimulated cell motility, we used antibody neutralization approach. As shown in Figure carried out histological analysis of wounds from three treatment groups, we noticed a dramatic difference in quality between Hsp90α-and Hsp90β-repaired wounds. As shown in Figure 2D , the Hsp90α-treated wounds achieved the similar epidermal thickness as that of unwounded skin (panel c' vs. panel a'). CMC treatment showed significant reduction in the epidermal thickness (panel b'). However, the worst outcome in thickness of the re-epithelialized epidermis came from the Hsp90β-treated wounds, which closed on the same day to the naked eye as other treatments but had extremely thin epidermis (panel d'). We concluded that extracellular Hsp90α is superior to Hsp90β in promoting wound healing quantitatively and, moreover, qualitatively.
Nonetheless, the reason for Hsp90β to promote wound closure remains unclear and the possibilities include its effect on wound contraction or its lower pro-motility activity on skin cells as we previously reported (Cheng et al., 2008) or both.
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The role for Hsp90 is to bind and stabilize LRP-1 receptor from inside the cell.
What is the role for Hsp90 in promoting HDF motility in response to hypoxia? We focused on the stability of LDL receptor-related protein-1 (LRP-1), the cell surface receptor that mediates hypoxia-induced cell migration (Cheng et al., 2008; Woodley et al., 2009) . We first examined which Hsp90 isoform, Hsp90α or Hsp90β, binds to the short (100 amino acids) cytoplasmic tail of LRP-1 as a chaperone. To focus on the cytoplasmic tail only, we pre-incubated the cells with RAP (receptor-associated protein) prior to lysis of the cells. Since RAP is known to bind to and block the entire extracellular ligand binding domains of LRP-1, this "pre-occupying" approach prevented endogenous Hsp90 from binding to the extracellular part of LRP-1 after cell lysis.
Anti-LRP-1 immunoprecipitates of the cell lysates were subjected to Western blot analysis with anti-Hsp90α or anti-Hsp90β antibodies to identify LRP-1-associated Hsp90 isoform protein(s).
As shown in Figure 3A , increasing concentrations of RAP protein in pre-incubation did not affect the amount of LRP-1-associated Hsp90β (panel a, lanes 1-3) . The slight increase in Hsp90β binding to LRP-1 was likely due to less internalization of LRP-1 following RAP binding from outside the cells (Bu et al., 2000) . Surprisingly, however, we were unable to detect any Hsp90 from anti-LRP-1 immunoprecipitates (panel b). Equal amounts of LRP-1 pull-down from the cells were verified by blotting the immunoprecipitates (10%) with an anti-LRP-1 antibody (panel c) (Note: the 150-kDa, instead of 55-kDa, IgG in the SDS-PAGE gel was due to the required non-reducing working condition for the anti-LRP-1 antibody). These data indicate that Hsp90, but not Hsp90, binds to the cytoplasmic tail of LRP-1 receptor. Therefore, Hsp90 acted as an intracellular chaperone to stabilize LRP-1 at the cell surface and allowed secreted Hsp90α to bind LRP-1 and initiate cell motility signaling. Indeed, as shown in Figure   3B We expected that the shRNA-Hsp90β + exogenous Hsp90β-overexpresssed HDFs should behave like their wild type counterparts and regain enhanced motility in response to hypoxia and extracellular Hsp90α stimulation. As shown in Figure 4A , Hsp90 downregulation inhibited hypoxia-stimulated (bar 6 vs. bar 3) and Hsp90α-stimulated (bar 5 vs. bar 2) cell migration.
Exogenous re-expression of Hsp90β, which restored the downregulated LRP-1 receptor, corrected the defects (bars 8 and 9). In contrast, overexpression of Hsp90α was unable to do the same (bars 11 and 12). More convincingly, directly re-introducing a LRP-1 gene into Hsp90β-downregulated HDFs also restored the cell motility. As shown in Figure 4B Figure 4D . We believe that this mechanism applies not only to skin wound healing but broadly to other tissue repairs, as well as tumor progression where secreted Hsp90α plays a critical role.
Hsp90β gene knockout is embryonic lethal in mice (Voss et al., 2000) . In contrast, mice developed normally without functional Hsp90α (Grad et al., 2010; Imai et al., 2011) . These studies support the notion that Hsp90β, but not Hsp90α, represents the long recognized "chaperone" protein that maintains the intracellular signaling networks essential for life. In contrast, Hsp90α plays less chaperone role inside the cells than Hsp90β. We argue that Hsp90α is mainly an extracellular tissue repair molecule. Two recent studies showed that conditional deletion of Hsp90α in adult mice causes defects in piRNA biogenesis and spermatogenesis (Ichiyanagi et al., 2014; Kajiwara et al. 2012) . There are two possible explanations of the findings. First, Hsp90α acts as a chaperone in these cellular events. The other is that those defects may also be due to lack of the extracellular functions of Hsp90α, in particular for spermatogenesis where the local environment is hypoxic with lower temperature than rest of the body. A key future experiment is to test if extracellular supplementation of the cells isolated from the mice with purified Hsp90α protein rescues the defects.
Methods
Primary human dermal fibroblasts were purchased from Clonetics (San Diego, CA) and were cultured in DMEM supplemented with 10% fetal bovine serum. The 3 rd or 4 th passages were used in cell migration assays. rhPDGF-BB was purchased from R&D System. Antibodies against PDGFR- (3169) and EGFR (4267) were from Cell Signaling Technologies (Dancers, MA).
Anti-LRP1/CD91 antibody (37-7600) was purchased from Life Technologies (Grand Island, NY). Mouse monoclonal antibodies against Hsp90α (CA1023) and Hsp90β (SMC 107) were from Calbiochem (Billerica, MA) and Stressmarq Biosciences (Victoria, BC, Canada), respectively. Anti-GAPDH antibody (GTX28245) antibody was from Genetex (Irvine, CA).
Recombinant RAP protein was as previously described (Cheng et al., 2008) .
Recombinant Hsp90 and Hsp90β proteins production and purification
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Cell migration assay
The colloidal gold migration assay was modified and described previously in details by us (Li et al., 2004) . Data from independent experiments (n  3) were averaged and calculated as Migration Index (MI, %).
Chemotaxis assay
The transwell motility assay was carried out according to the manufacturer's instruction (Cat no.
3422, Corning Life Sciences, Tewksbury, MA).
The lentiviral systems
Utilization of lentiviral systems for down-regulation and overexpression of genes are as previously described (Li et al., 2007; Cheng et al., 2008; Sahu et al., 2012) . The shRNA sequences for human Hsp90α: GGAAAGAGCTGCATATTAA (sense) and for human Hsp90β: GCATCTATCGCATGATCAA (sense).
Preparation of carboxymethylcellulose gel with Hsp90, wound healing, H&E and IHC staining and Statistics
See details as previously described (O'Brien et al., 2014) .
Reverse Transcriptase PCR (RT-PCR)
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